CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes

Glia. 2009 Feb;57(3):295-306. doi: 10.1002/glia.20757.

Abstract

Regulation of Ca(2+) homeostasis plays a critical role in oligodendrocyte function and survival. Cannabinoid CB(1) and CB(2) receptors have been shown to regulate Ca(2+) levels and/or K(+) currents in a variety of cell types. In this study we investigated the effect of cannabinoid compounds on the Ca(2+) influx elicited in cultured oligodendrocytes by transient membrane depolarization with an elevated extracellular K(+) concentration (50 mM). The CB(1) receptor agonist arachidonoyl-chloro-ethanolamide (ACEA) elicited a concentration-dependent inhibition of depolarization-evoked Ca(2+) transients in oligodendroglial somata with a maximal effect (94+/-3)% and an EC(50) of 1.3+/-0.03 microM. This activity was mimicked by the CB(1)/CB(2) agonist CP55,940, as well as by the endocannabinoids N-arachidonoyl-ethanolamine (anandamide, AEA) and 2-arachidonoylglycerol (2-AG), whereas the CB(2) receptor selective agonist JWH133 was ineffective. The CB(1) receptor antagonist AM251 (1 microM) also reduced the Ca(2+) response evoked by high extracellular K(+) and did not prevent the inhibition elicited by ACEA (3 microM). Nevertheless, the ability of ACEA and AEA to reduce depolarization-evoked Ca(2+) transients was significantly reduced in oligodendrocytes from CB(1) receptor knockout mice, as well as by pretreatment with pertussis toxin. Bath application of the inwardly rectifying K(+) channels (Kir channels) blockers BaCl(2) (300 microM) and CsCl(2) (1 mM) reduced the size of voltage-induced Ca(2+) influx and partially prevented the inhibitory effect of ACEA. Our results indicate that cannabinoids inhibit depolarization-evoked Ca(2+) transients in oligodendrocytes via CB(1) receptor-independent and -dependent mechanisms that involve the activation of PTX-sensitive G(i/o) proteins and the blockade of Kir channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Arachidonic Acids / pharmacology
  • Calcium / metabolism*
  • Calcium Channels / pharmacology
  • Cannabinoid Receptor Modulators / metabolism
  • Cannabinoids / pharmacology
  • Cyclohexanols / pharmacology
  • Dose-Response Relationship, Drug
  • Endocannabinoids
  • GTP-Binding Proteins / physiology
  • Immunosuppressive Agents / pharmacology
  • Mice
  • Mice, Knockout
  • Oligodendroglia / drug effects
  • Oligodendroglia / metabolism*
  • Optic Nerve / cytology
  • Polyunsaturated Alkamides / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels / physiology
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Cannabinoid, CB1 / agonists
  • Receptor, Cannabinoid, CB1 / antagonists & inhibitors
  • Receptor, Cannabinoid, CB1 / deficiency
  • Receptor, Cannabinoid, CB1 / metabolism*
  • Receptor, Cannabinoid, CB2 / agonists
  • Receptor, Cannabinoid, CB2 / antagonists & inhibitors
  • Receptor, Cannabinoid, CB2 / genetics
  • Receptor, Cannabinoid, CB2 / metabolism
  • Time Factors

Substances

  • Arachidonic Acids
  • Calcium Channels
  • Cannabinoid Receptor Modulators
  • Cannabinoids
  • Cnr2 protein, rat
  • Cyclohexanols
  • Endocannabinoids
  • Immunosuppressive Agents
  • Polyunsaturated Alkamides
  • Potassium Channel Blockers
  • Potassium Channels
  • RNA, Messenger
  • Receptor, Cannabinoid, CB1
  • Receptor, Cannabinoid, CB2
  • 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
  • GTP-Binding Proteins
  • Calcium
  • 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC
  • anandamide